Aclaris Therapeutics, Inc.
ACRSBiotechnology
$3.99+0.76%As of Oct 29vs prior close
- Market cap
- $587.3M
- P/E (TTM)
- –
- From 52W high
- −38.94%
- EPS (LTM)
- -$0.58
- Revenue (LTM)
- $8.2M
- Net margin
- -921.50%
- Dividend yield
- 0.00%
Nomior Score
37
Steady ProfileSpeculativeBottom 25% of the scored universe
Growth24
Quality35
Value36
Momentum92
Resilience30
Growth
+21.18%revenue a year over 8 fiscal years
YE17 $1.7MLTM $8.2M
Connections
Revenue to profitQ2 YE26
The operating loss was 1488% of revenue, wider by 452 pts on a year.
Who owns it
2funds